Sinonasal hemangiopericytoma: A rare case report with review of literature

Hemangiopericytoma (HPC) is a rare tumor of uncertain malignant potential. Stout and Murray described HPC as “vascular tumor arising from Zimmerman's pericyte” in 1942. The World Health Organization (WHO) reclassified HPC as a fibroblastic/myofibroblastic tumor, after further characterization....

Full description

Bibliographic Details
Main Authors: Shobha, BV, Shivakumar, BN, Reddy, Santhosh, Dutta, Neerav
Format: Online
Language:English
Published: Medknow Publications & Media Pvt Ltd 2015
Online Access:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4451651/
id pubmed-4451651
recordtype oai_dc
spelling pubmed-44516512015-06-19 Sinonasal hemangiopericytoma: A rare case report with review of literature Shobha, BV Shivakumar, BN Reddy, Santhosh Dutta, Neerav Case Report Hemangiopericytoma (HPC) is a rare tumor of uncertain malignant potential. Stout and Murray described HPC as “vascular tumor arising from Zimmerman's pericyte” in 1942. The World Health Organization (WHO) reclassified HPC as a fibroblastic/myofibroblastic tumor, after further characterization. HPC is found mostly wherever there is increased vascularity seen. The incidence of the tumor in head and neck area is only 15%, mostly seen in adults. We report here a case of HPC of a 22-year-old female, who presented to our department with a tender swelling in maxillary anterior region and the mass was well-circumscribed, sessile and soft on palpation. The skin over the tumor was intact and normal. The tumor was completely removed with wide surgical resection. The histopathological staining supported the diagnosis of HPC, this was further confirmed by immunohistochemistry (IHC) in which CD99 showed strong positivity. Medknow Publications & Media Pvt Ltd 2015 /pmc/articles/PMC4451651/ /pubmed/26097321 http://dx.doi.org/10.4103/0973-029X.157214 Text en Copyright: © Journal of Oral and Maxillofacial Pathology http://creativecommons.org/licenses/by-nc-sa/3.0 This is an open-access article distributed under the terms of the Creative Commons Attribution-Noncommercial-Share Alike 3.0 Unported, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
repository_type Open Access Journal
institution_category Foreign Institution
institution US National Center for Biotechnology Information
building NCBI PubMed
collection Online Access
language English
format Online
author Shobha, BV
Shivakumar, BN
Reddy, Santhosh
Dutta, Neerav
spellingShingle Shobha, BV
Shivakumar, BN
Reddy, Santhosh
Dutta, Neerav
Sinonasal hemangiopericytoma: A rare case report with review of literature
author_facet Shobha, BV
Shivakumar, BN
Reddy, Santhosh
Dutta, Neerav
author_sort Shobha, BV
title Sinonasal hemangiopericytoma: A rare case report with review of literature
title_short Sinonasal hemangiopericytoma: A rare case report with review of literature
title_full Sinonasal hemangiopericytoma: A rare case report with review of literature
title_fullStr Sinonasal hemangiopericytoma: A rare case report with review of literature
title_full_unstemmed Sinonasal hemangiopericytoma: A rare case report with review of literature
title_sort sinonasal hemangiopericytoma: a rare case report with review of literature
description Hemangiopericytoma (HPC) is a rare tumor of uncertain malignant potential. Stout and Murray described HPC as “vascular tumor arising from Zimmerman's pericyte” in 1942. The World Health Organization (WHO) reclassified HPC as a fibroblastic/myofibroblastic tumor, after further characterization. HPC is found mostly wherever there is increased vascularity seen. The incidence of the tumor in head and neck area is only 15%, mostly seen in adults. We report here a case of HPC of a 22-year-old female, who presented to our department with a tender swelling in maxillary anterior region and the mass was well-circumscribed, sessile and soft on palpation. The skin over the tumor was intact and normal. The tumor was completely removed with wide surgical resection. The histopathological staining supported the diagnosis of HPC, this was further confirmed by immunohistochemistry (IHC) in which CD99 showed strong positivity.
publisher Medknow Publications & Media Pvt Ltd
publishDate 2015
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4451651/
_version_ 1613230379123081216